Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bain

Showing results (411-420 of 494) with videos related to

Pageof 50
Sort By:
Diabetologia|August 21, 2013
High frequency of autoantibodies in patients with long duration type 1 diabetesCarolyn C Richardson, James A Dromey, Kerry A McLaughlin, et al.
Diabetes, Obesity & Metabolism|October 15, 2019
Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: A patient-level, pooled analysis of the SUSTAIN 1-5 trialsVanita R Aroda, Matthew S Capehorn, Louis Chaykin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 10, 2021
Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational StudyDavid M Williams, Aliya M Ruslan, Rahim Khan, et al.
Nature Genetics|November 1, 1992
Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individualsS C Bain, J B Prins, C M Hearne, et al.
Diabetes, Obesity & Metabolism|July 4, 2020
Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trialOfri Mosenzon, Stephen C Bain, Hiddo J L Heerspink, et al.
Circulation|October 26, 2018
Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin UseSubodh Verma, Lawrence A Leiter, C David Mazer, et al.
Journal of Clinical and Translational Science|June 30, 2021
Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemicLeslie Bobb, Lisa Richman Ballance, Antonio Abbate, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 30, 2015
Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetesD Turner, S Luzio, B J Gray, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 17, 2026
Dynamic changes to the intestinal environment occur throughout recovery from experimental ischaemic strokeRachel M L Martin, Isobel C Mouat, Robert J Whelan, et al.
Diabetes|November 1, 1996
Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12M M Byrne, J Sturis, S Menzel, et al.
Pageof 50

Showing results (411-420 of 494) with videos related to

Sort By:
Pageof 50
Diabetologia|August 21, 2013
High frequency of autoantibodies in patients with long duration type 1 diabetesCarolyn C Richardson, James A Dromey, Kerry A McLaughlin, et al.
Diabetes, Obesity & Metabolism|October 15, 2019
Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: A patient-level, pooled analysis of the SUSTAIN 1-5 trialsVanita R Aroda, Matthew S Capehorn, Louis Chaykin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 10, 2021
Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational StudyDavid M Williams, Aliya M Ruslan, Rahim Khan, et al.
Nature Genetics|November 1, 1992
Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individualsS C Bain, J B Prins, C M Hearne, et al.
Diabetes, Obesity & Metabolism|July 4, 2020
Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trialOfri Mosenzon, Stephen C Bain, Hiddo J L Heerspink, et al.
Circulation|October 26, 2018
Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin UseSubodh Verma, Lawrence A Leiter, C David Mazer, et al.
Journal of Clinical and Translational Science|June 30, 2021
Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemicLeslie Bobb, Lisa Richman Ballance, Antonio Abbate, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 30, 2015
Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetesD Turner, S Luzio, B J Gray, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 17, 2026
Dynamic changes to the intestinal environment occur throughout recovery from experimental ischaemic strokeRachel M L Martin, Isobel C Mouat, Robert J Whelan, et al.
Diabetes|November 1, 1996
Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12M M Byrne, J Sturis, S Menzel, et al.
Pageof 50